Consistent with the present results, changes in MeCP2 binding and hypermethylation in Reln promoter are associated with major mental illnesses such as Schizophrenia, bipolar disorder (Mitchell et al., 2005; Zhubi et al., 2014; Teroganova et al., 2016). This evidence concerns the gene MECP2 and bipolar disorder.